Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 65, Issue 6, Pages 1891-1903
Publisher
Wiley
Online
2017-01-30
DOI
10.1002/hep.29090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease
- (2016) Arun J. Sanyal et al. GASTROENTEROLOGY
- Regulatory Science and Drug Approval for Alcoholic and Nonalcoholic Steatohepatitis
- (2016) Arun J. Sanyal et al. GASTROENTEROLOGY
- Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood
- (2016) Martin L. Decaris et al. HEPATOLOGY
- MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
- (2016) Parambir S. Dulai et al. JOURNAL OF HEPATOLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
- (2015) Arun J. Sanyal et al. HEPATOLOGY
- Data-driven desirability function to measure patients’ disease progression in a longitudinal study
- (2015) Hsiu-Wen Chen et al. JOURNAL OF APPLIED STATISTICS
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Automated biphasic morphological assessment of hepatitis B-related liver fibrosis using second harmonic generation microscopy
- (2015) Tong-Hong Wang et al. Scientific Reports
- qFibrosis: A fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients
- (2014) Shuoyu Xu et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease: What the Pathologist Can Tell the Clinician
- (2012) Elizabeth M. Brunt DIGESTIVE DISEASES
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- Use of desirability functions to evaluate health status in patients with cirrhosis
- (2010) Chris Gennings et al. JOURNAL OF HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease
- (2008) Valerio Nobili et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started